U.S. Logistics Stock News

NYSE:WSM
NYSE:WSMSpecialty Retail

Williams Sonoma (WSM) Margin Decline Questions Premium P E Narrative After FY 2026 Results

Williams-Sonoma (WSM) has wrapped up FY 2026 with fourth quarter revenue of US$2.4b and basic EPS of US$3.09, set against a trailing twelve month revenue base of US$7.8b and EPS of US$8.96. Over recent quarters the company has seen revenue move from US$2.5b in Q4 FY 2025 to US$2.4b in Q4 FY 2026, while quarterly EPS shifted from US$3.12 to US$3.09. This is prompting investors to focus on how modest growth expectations line up with a slightly lower trailing net margin and what that may...
NasdaqGS:ALAB
NasdaqGS:ALABSemiconductor

Assessing Astera Labs (ALAB) Valuation After Amazon Warrant Deal And Growing AI Supplier Confidence

Amazon warrant deal and GTC spotlight put Astera Labs in focus Astera Labs (ALAB) has moved into the spotlight after a US$6.5b warrant agreement with Amazon and a scheduled presentation at NVIDIA’s GTC AI Conference 2026 in San Jose on March 17. See our latest analysis for Astera Labs. Despite the excitement around the Amazon warrant deal and GTC appearance, Astera Labs’ 90 day share price return of 13.39% and year to date share price return of 29.64% point to fading short term momentum,...
NYSE:FG
NYSE:FGInsurance

A Look At F&G Annuities & Life (FG) Valuation After New US$100 Million Buyback Approval

F&G Annuities & Life (FG) has drawn fresh attention after its Board approved a new stock repurchase program of up to US$100 million through March 31, 2029, expanding existing buyback capacity. See our latest analysis for F&G Annuities & Life. The announcement comes after a period where momentum in FG has cooled. The 7 day share price return was 12.29%, following a 30 day share price decline of 16.77% and a 1 year total shareholder return of 42.81% in decline. If you are reassessing your...
NasdaqGS:HOLX
NasdaqGS:HOLXMedical Equipment

Is It Time To Reconsider Hologic (HOLX) After A 30% DCF Valuation Gap?

If you are wondering whether Hologic at around US$75.15 is priced for opportunity or already reflects much of the story, the valuation picture is the place to start. The stock has been relatively steady in the short term, with a 0.3% decline over the last 7 days and a 0.1% gain over 30 days, while the 1 year return of 22.3% contrasts with modest 3 year and 5 year returns of 4.4% and 4.4%. Recent coverage has focused on Hologic as a key medical technology player, with attention on how its...
NYSE:HRL
NYSE:HRLFood

Hormel Foods (HRL) Valuation Check After Limited Edition SPAM Bachan’s Collaboration

SPAM’s New Collaboration Puts Hormel Foods in the Spotlight Hormel Foods (HRL) is drawing fresh attention after its SPAM brand partnered with Bachan's to launch a limited edition SPAM Japanese Barbecue Sauce Flavored product, inspired by fan driven recipes and social media trends. See our latest analysis for Hormel Foods. Despite the buzz around SPAM’s latest launch, Hormel Foods’ 1 month share price return of 4.5% and 1 year total shareholder return of 20.3% decline suggest momentum has been...
NYSE:QBTS
NYSE:QBTSSoftware

D-Wave Quantum Expands Gate-Model Reach As QCaaS Bookings Gain Traction

D-Wave Quantum (NYSE:QBTS) has agreed to acquire Quantum Circuits, Inc., expanding into gate-model quantum computing alongside its existing quantum annealing focus. The company has also secured a significant enterprise Quantum-Compute-as-a-Service (QCaaS) agreement, signaling growing commercial use of its quantum offerings. These developments arrive alongside a surge in bookings, pointing to increasing customer engagement with D-Wave's technology stack. D-Wave Quantum operates as a quantum...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Assessing Critical Metals (CRML) Valuation As Greenland Rare Earth Plans Accelerate And Capital Options Expand

Shelf registration signals push to fund Greenland rare earth plans Critical Metals (CRML) has filed a US$25.2 million shelf registration covering 2,744,062 ordinary shares. This provides the company with flexibility to access equity markets as it advances its Greenland focused rare earth portfolio. See our latest analysis for Critical Metals. The share price has been volatile around the recent news flow, with a 7 day share price return of 10.10% decline and a 90 day share price return of...
NYSEAM:TMP
NYSEAM:TMPBanks

Will Tompkins Financial’s New Bank President-Elect Reshape Its Long-Term Strategy Story (TMP)?

Tompkins Financial Corp. recently announced that Phillip M. Quintana has been appointed President-Elect of Tompkins Community Bank, succeeding long-serving president John McKenna upon his planned retirement in July 2026. This leadership transition brings more than 27 years of banking leadership experience into a central role at Tompkins Community Bank, potentially influencing its commercial, retail, and credit operations. With this leadership succession plan now public, we’ll assess how...
NasdaqGS:MCHP
NasdaqGS:MCHPSemiconductor

Mythic’s Neuromorphic Design Win Might Change The Case For Investing In Microchip Technology (MCHP)

In early March 2026, Mythic announced it had selected Microchip Technology’s Silicon Storage Technology memBrain neuromorphic hardware IP, using SuperFlash embedded non-volatile memory bitcells to power its next-generation analog processing units for edge and data center AI acceleration. This design win highlights Microchip’s role as an enabling IP provider for power-efficient AI hardware, potentially expanding its reach beyond traditional microcontrollers into compute-in-memory...
NYSE:SLG
NYSE:SLGOffice REITs

SL Green Refocuses Portfolio As 7 Dey Sale Meets Leasing Momentum

SL Green Realty (NYSE:SLG) has agreed to sell the residential and retail components of 7 Dey Street. The company reports that One Madison Avenue is now fully leased. SL Green also highlights significant Manhattan leasing activity so far this year. For investors watching NYSE:SLG, these updates come at a time when the stock trades at $38.37 and has seen very different returns over various time frames, with a 1.5% gain over the past week alongside a 31.8% decline over the past year and a...
NasdaqGS:KMB
NasdaqGS:KMBHousehold Products

Kimberly-Clark (KMB) Valuation Check As Portfolio Reshaping And Kenvue Deal Follow Strong Sales And Dividend Focus

Kimberly-Clark (KMB) has been in focus after divesting its U.S. private label diaper business, reporting strong organic sales and adjusted operating profit, and preparing for the pending Kenvue acquisition while maintaining its long dividend track record. See our latest analysis for Kimberly-Clark. Despite the recent business reshaping and leadership changes, including the appointment of a new Chief Information and Global Business Services Officer, Kimberly-Clark’s 30-day share price return...
NYSE:BE
NYSE:BEElectrical

Bloom Energy (BE) Valuation Check As Brookfield’s US$5b Data Center Partnership Targets Rising AI Power Demand

Bloom Energy (BE) is back in focus after Brookfield Asset Management agreed to invest up to US$5 billion to deploy the company’s fuel cell systems in data centers serving growing AI power needs. See our latest analysis for Bloom Energy. The Brookfield deal follows a powerful run in Bloom Energy’s shares, with a 90 day share price return of 95.21% and a year to date share price return of 58.66%. The 1 year and 3 year total shareholder returns are very large, signalling strong momentum despite...
NasdaqCM:ONCY
NasdaqCM:ONCYBiotechs

Is It Time To Reconsider Oncolytics Biotech (ONCY) After A Huge DCF Valuation Gap?

Wondering if Oncolytics Biotech at around US$0.96 is attractively priced or a value trap? This article walks through the key signals to help you frame that question clearly. The stock has seen mixed returns, with a 54.8% gain over the past year contrasted by a 4.9% decline over 7 days, a 9.4% decline over 30 days, and a 2.4% decline year to date, plus a 21.3% decline over 3 years and a 76.6% decline over 5 years. Recent attention on the company has focused on its position in the biotech...
NYSE:APTV
NYSE:APTVAuto Components

Aptiv’s Ethics Streak Meets Versigent Spin Off And Debt Rework

Aptiv (NYSE:APTV) has been named one of the 2026 World’s Most Ethical Companies by Ethisphere. This is the 14th consecutive year the company has received this recognition. The award highlights Aptiv’s focus on ethics, integrity, and governance in its global operations. Aptiv, a global technology company serving the automotive and mobility sectors, operates at the intersection of vehicle electronics, safety systems, and software defined features. As the industry moves toward more connected...
NasdaqGS:FFIV
NasdaqGS:FFIVCommunications

Is It Time To Reconsider F5 (FFIV) After Its Recent Mixed Share Price Performance?

Wondering if F5 at around US$282.20 is offering good value or asking too much? This breakdown is designed to help you frame that question clearly before you make any moves. The stock has seen mixed recent returns, with a 2.5% decline over the last 7 days, a 3.0% gain over the past month, 10.0% year to date, and 4.4% over the last year. The 3 year and 5 year returns stand at 100.6% and 42.7% respectively. Recent coverage around F5 has focused on how investors are weighing long term...
NYSE:ADC
NYSE:ADCRetail REITs

How Agree Realty’s Higher Monthly Dividend and Institutional Demand Will Impact Agree Realty (ADC) Investors

Agree Realty Corporation recently declared a monthly cash dividend of US$0.262 per common share and US$0.08854 per Series A preferred depositary share, with the payouts scheduled in April 2026 to shareholders of record in March, marking an annualized increase in the common dividend. This dividend increase, alongside very large growth in institutional holdings and reaffirmed analyst confidence, highlights how income-focused investors view Agree Realty’s retail-focused portfolio as an...
NYSE:JNJ
NYSE:JNJPharmaceuticals

Does FDA Approval Of Oral Psoriasis Drug ICOTYDE Reshape The Bull Case For Johnson & Johnson (JNJ)?

On 18 March 2026, Johnson & Johnson received U.S. FDA approval for ICOTYDE (icotrokinra), the first targeted oral IL-23 receptor antagonist for moderate-to-severe plaque psoriasis in adults and eligible adolescents, supported by Phase 3 data showing strong skin clearance rates and a safety profile close to placebo at 16 weeks. Beyond psoriasis, ICOTYDE is being investigated in psoriatic arthritis, ulcerative colitis and Crohn’s disease, positioning it as a potential oral backbone across...
NYSE:LEN
NYSE:LENConsumer Durables

How Investors May Respond To Lennar (LEN) Earnings Drop Amid Aggressive Buybacks And Steady Build Targets

Lennar Corporation’s first-quarter 2026 results, released in March, showed revenue of US$6,619.48 million and net income of US$229.38 million, with earnings per share from continuing operations at US$0.93, all down from the prior year despite ongoing homebuilding activity. Alongside these results, Lennar completed a multi‑year buyback totaling 65,185,859 shares for US$7,602.91 million and guided to delivering roughly 20,000 to 21,000 homes in the second quarter of 2026, underscoring its...
NYSE:NAT
NYSE:NATOil and Gas

Nordic American Tankers Vessel Sale Puts Focus On Fleet And Valuation

Nordic American Tankers (NYSE:NAT) has agreed to sell a 2005 built vessel for around US$40 million. Management describes the transaction as aligned with the company’s current positioning and plans for future fleet growth. The deal affects fleet composition and adds flexibility around capital allocation going forward. The sale comes as Nordic American Tankers trades at a share price of US$5.42, with the stock up 3.4% over the past week and 19.4% over the past month. Returns of 60.8% year to...
NasdaqGS:GEHC
NasdaqGS:GEHCMedical Equipment

Assessing GE HealthCare Technologies (GEHC) Valuation After New AI Launches And FDA Clearance For Genesis Radiology Workspace

GE HealthCare Technologies (GEHC) has drawn fresh attention after securing FDA 510(k) clearance for its Genesis Radiology Workspace viewer, called View, shortly after showcasing a broad suite of AI-powered health IT solutions at HIMSS 2026. See our latest analysis for GE HealthCare Technologies. Despite the recent HIMSS 2026 showcase and FDA clearance for View, momentum in the stock has cooled, with a 1-month share price return decline of 12.56% and a 1-year total shareholder return decline...
NYSE:COHR
NYSE:COHRElectronic

How NVIDIA Optics Deal and S&P 500 Entry Will Impact Coherent (COHR) Investors

Coherent Corp. recently announced a multiyear optics partnership with NVIDIA that includes a multibillion-dollar purchase commitment and a US$2.00 billion investment to expand R&D and U.S. manufacturing, alongside its upcoming addition to the S&P 500 index and a broad showcase of AI-focused optical technologies at OFC 2026. By pairing deep involvement in next-generation AI datacenter optics with index inclusion and long-term NVIDIA demand visibility, Coherent is strengthening its position as...
NYSE:DOV
NYSE:DOVMachinery

What Dover (DOV)'s Wells Fargo Upgrade and Buyback Plan Means For Shareholders

In the past week, Wells Fargo upgraded Dover Corporation to Overweight, citing accelerating organic growth, margin expansion from restructuring efforts, and a supportive U.S. industrial demand backdrop alongside limited Middle East exposure. The upgrade also drew attention to Dover’s Q4 2025 organic growth of 5.0%, 2026 adjusted EPS guidance of US$10.45–US$10.65, and a US$500 million accelerated share repurchase that together emphasize management’s focus on earnings resilience and capital...
NYSE:CDE
NYSE:CDEMetals and Mining

A Look At Coeur Mining (CDE) Valuation After The Recent Share Price Pullback

Context for Coeur Mining’s Recent Share Performance With no single headline event driving attention, Coeur Mining (CDE) has drawn interest after an 8.5% decline over the past day and a 14% drop over the past week, despite positive longer term returns. See our latest analysis for Coeur Mining. At a share price of US$19.26, Coeur’s recent 1 day and 1 month share price declines sit against a stronger backdrop, with a positive 90 day share price return and very large multi year total shareholder...
NYSE:TFC
NYSE:TFCBanks

A Look At Truist Financial (TFC) Valuation As New Payments Leadership And Plaid Agreement Shape Growth Plans

Truist Financial (TFC) has been active in payments, with new leadership hires in its Enterprise Payments business and a fresh data access agreement with Plaid Inc., drawing more attention to its stock. See our latest analysis for Truist Financial. Despite the payments push and open banking agreement with Plaid, Truist Financial’s share price has slid recently, with a 30 day share price return of a 15.51% decline and a year to date share price return of an 11.84% decline. However, its 1 year...